Company
Vera Therapeutics, Inc. (VERA)
Standardized SEC financial data for Vera Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001831828 · NASDAQ · Pharmaceutical Preparations.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| R&D expense | $45.2M | $22.5M | $69.0M | $78.2M | $126.2M | $215.3M |
| SG&A expense | $4.0M | $11.9M | $21.9M | $23.8M | $41.0M | $100.2M |
| Operating income | -$52.2M | -$34.4M |
Standardized from Vera Therapeutics, Inc.'s SEC filings — per-share figures split-adjusted. Full history via the API.
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $54.0M | $80.0M | $43.8M | $45.7M | $92.6M | $354.7M |
| Total current assets |
Get VERA data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/VERA/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/VERA/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"